A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| 8-Aminoguanosine | 8-Aminoguanosine. Group: Biochemicals. Grades: Highly Purified. CAS No. 3868-32-4. Pack Sizes: 100mg, 250mg, 500mg, 1g, 2g. Molecular Formula: C10H14N6O5. US Biological Life Sciences. |  Worldwide |
| 8-Aminoguanosine | A potent inhibitor of purine nucleoside phosphorylase. Uses: A potent inhibitor of purine nucleoside phosphorylase. Synonyms: 2,8-Diaminoinosine; NSC 90390. Grades: 98%. CAS No. 3868-32-4. Molecular formula: C10H14N6O5. Mole weight: 298.26. |  |
| 8-Aminoguanosine | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| 8-Aminoguanosine (2,8-Diaminoinosine) | A potent inhibitor of purine nucleoside phosphorylase. Group: Biochemicals. Alternative Names: 2,8-Diaminoinosine. Grades: Highly Purified. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| 8-Aminohypoxanthine | 8-Aminohypoxanthine. Group: Biochemicals. Alternative Names: 8-Amino-1,9-dihydro-6H-purin-6-one. Grades: Highly Purified. CAS No. 45893-20-7. Pack Sizes: 0.25g. Molecular Formula: C5H5N5O, Molecular Weight: 151.13. US Biological Life Sciences. | Worldwide |
| 8-Amino-Inosine | 8-Amino-Inosine. Group: Biochemicals. Alternative Names: NSC 109320. Grades: Highly Purified. CAS No. 13389-16-7. Pack Sizes: 25mg. Molecular Formula: C10H13N5O5, Molecular Weight: 283.24. US Biological Life Sciences. | Worldwide |
| 8-Amino-Inosine | 8-Amino-Inosine is a derivative of Inosine, a nucleoside that is found in tRNAs and is essential for the proper translation of genetic code in a wobble base pair. Inosine is also known to exert neuroprotective properties and has been used to treat stroke patients to restore neural function. 8-Amino-Inosine have been studied as a potential chemotherapeutic agent for the treatment of leukemia function by the cytodestruction of the neoplastic cells. Synonyms: NSC 109320. Grades: 96%. CAS No. 13389-16-7. Molecular formula: C10H13N5O5. Mole weight: 283.24. | |
| 8-Aminoisoquinoline ≥97% (HPLC) | 8-Aminoisoquinoline ≥97% (HPLC). Group: Biochemicals. Grades: Reagent Grade. CAS No. 23687-27-6. Pack Sizes: 1g, 5g, 25g. US Biological Life Sciences. | Worldwide |
| 8-Aminonaphthalene-1,3,6-trisulfonic acid disodium salt | BioReagent, suitable for fluorescence, ?90% (CE). Group: Fluorescence/luminescence spectroscopy. | |
| 8-Aminooctanoic acid | 8-Aminooctanoic acid. CAS No: 1002-57-9 |  Sarchem Laboratories New Jersey NJ |
| 8-Aminopurine | 8-Aminopurine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-AMINOPURINE;1H-Purin-8-amine (9CI);8-Amino-7H-purine;1H-Purine-8-amine;8-Amino-9H-purine;9H-Purin-8-amine. Product Category: Heterocyclic Organic Compound. CAS No. 20296-09-7. Molecular formula: C5H5N5. Mole weight: 135.13. Product ID: ACM20296097. Alfa Chemistry ISO 9001:2015 Certified. Categories: 7H-purin-8-amine. |  |
| 8-Aminopyrene-1,3,6-trisulfonic acid sodium salt | 8-Aminopyrene-1,3,6-trisulfonic acid is an anionic fluorescent probe for the detection of saccharides. It is pH-sesitive, with the emission maximum remaining constant over the pH range of 4-10. Synonyms: APTS; Trisodium 8-aminopyrene-1,3,6-trisulfonate; 8-amino-1,3,6-pyrenetrisulfonic acid trisodium salt. Grades: ≥95%. CAS No. 196504-57-1. Molecular formula: C16H8NNa3O9S3. Mole weight: 523.4. | |
| 8-Aminopyrene-1,3,6-trisulfonic acid trisodium | 8-Aminopyrene-1,3,6-trisulfonic acid trisodium is a water-soluble anionic fluorescent dye. The fluorescence intensity of 8-Aminopyrene-1,3,6-trisulfonic acid trisodium remains nearly constant over a pH range from 4 to 10 [1]. Uses: Scientific research. Group: Fluorescent dye. Alternative Names: APTS. CAS No. 196504-57-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-D0031. |  |
| 8-Aminopyrene-1,3,6-trisulfonic acid trisodium salt | 8-Aminopyrene-1,3,6-trisulfonic acid trisodium salt. Group: Biochemicals. Grades: Highly Purified. CAS No. 196504-57-1. Pack Sizes: 100mg, 250mg, 500mg, 1g. Molecular Formula: C16H8NNa3O9S3. US Biological Life Sciences. | Worldwide |
| 8-Aminoquinolin-6-ol | 8-Aminoquinolin-6-ol. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-AMINO-QUINOLIN-6-OL;WR-6890. Product Category: Heterocyclic Organic Compound. CAS No. 7402-16-6. Molecular formula: C9H8N2O. Mole weight: 160.17. Product ID: ACM7402166. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Aminoquinoline | 8-Aminoquinoline is a biochemical reagent that can be used as a biological material or organic compound for life science related research. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 578-66-5. Pack Sizes: 5 g; 10 g. Product ID: HY-W007317. | |
| 8-Aminoquinoline | 8-Aminoquinoline. Group: Biochemicals. Grades: Highly Purified. CAS No. 578-66-5. Pack Sizes: 10g, 25g, 50g, 100g, 250g. Molecular Formula: C9H8N2. US Biological Life Sciences. | Worldwide |
| 8-Aminoquinoline-7-carbaldehyde | 8-Aminoquinoline-7-carbaldehyde. Group: Organic light-emitting diode (oled) materials. Alternative Names: 8-aminoquinoline-7-carbaldehyde, 158753-17-4, 8-Amino-quinoline-7-carbaldehyde, CTK4C9839, MolPort-016-578-720, ANW-71451, AKOS006309006, 8-AMINO-7-QUINOLINECARBALDEHYDE, AG-L-22194, 8-AMINO-7-QUINOLINECARBOXALDEHYDE, AK-83521, KB-46635, FT-0682316, I14-14449. CAS No. 158753-17-4. Product ID: 8-aminoquinoline-7-carbaldehyde. Molecular formula: 172.18. Mole weight: C10< / sub>H8< / sub>N2< / sub>O. C1=CC2=C(C(=C(C=C2)C=O)N)N=C1. ZAMLCNSCTZZXCU-UHFFFAOYSA-N. 96%. |  |
| 8-Aminoquinoline, 98% | 8-Aminoquinoline, 98%. Uses: 8-aminoquinoline has been used in: preparation of base-stabilized terminal borylene complex of osmium spectrophotometric determination of bivalent palladium. Additional or Alternative Names: DTXSID4060369; AN-21475; AC1Q51CD; A3000/0126362; 8-amino quinoline; PS-5383; PubChem7574; quinolin-8-yl-amine; RTC-062235; AB00375631-02. Product Category: Quinolines. CAS No. 578-66-5. Molecular formula: C9H8N2. Mole weight: 144.177g/mol. IUPACName: quinolin-8-amine. Canonical SMILES: C1=CC2=C(C(=C1)N)N=CC=C2. ECNumber: 209-427-9. Product ID: ACM578665. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Aminoquinoline N-Oxide | 8-Aminoquinoline N-Oxide. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-Aminoquinoline N-Oxide, 92339-84-9, 8-Aminoquinoline, 1-oxide, ACMC-209rfg, AC1LC5RI, 1-Oxido-8-quinolinylamine, SureCN4136722, 1-oxidoquinolin-1-ium-8-amine, CTK5H1167, ANW-39818, AKOS015854666, AG-L-25103. Product Category: Heterocyclic Organic Compound. CAS No. 92339-84-9. Molecular formula: C9H8N2O. Mole weight: 160.17. Purity: >98.0%(GC)(T). IUPACName: 1-oxidoquinolin-1-ium-8-amine. Canonical SMILES: C1=CC2=C(C(=C1)N)[N+](=CC=C2)[O-]. Density: 1.27g/cm³. Product ID: ACM92339849. Alfa Chemistry ISO 9001:2015 Certified. | |
| 8-Aminospiro[4.5]decane hydrochloride | 8-Aminospiro[4.5]decane hydrochloride. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8-Aminospiro[4.5]decane hydrochloride. Product Category: Heterocyclic Organic Compound. CAS No. 3643-12-7. Molecular formula: C10H20ClN. Mole weight: 189.7255. Product ID: ACM3643127. Alfa Chemistry ISO 9001:2015 Certified. Categories: Spiro[4.5]decan-8-amine hydrochloride. | |
| 8-Anilino-1-naphthalenesulfonic acid | 8-Anilino-1-naphthalenesulfonic acid. Group: Biochemicals. Grades: Highly Purified. CAS No. 82-76-8. Pack Sizes: 100g, 250g, 500g, 1kg, 2kg. Molecular Formula: C16H13NO3S. US Biological Life Sciences. | Worldwide |
| 8-Anilino-1-naphthalenesulfonic acid ammonium salt | technical, ?90% (NT). Group: Fluorescence/luminescence spectroscopy. | |
| 8-Anilino-1-naphthalenesulfonic acid hemimagnesium salt hydrate | for fluorescence, ?95% (perchloric acid titration). Group: Fluorescence/luminescence spectroscopy. | |
| 8-Anilino-1-naphthalenesulfonic acid (Phenyl peri acid) | 25g Pack Size. Group: Amines, Building Blocks, Organics, Stains & Indicators. Formula: C6H5NHC10H6SO3H. CAS No. 82-76-8. Prepack ID 12709547-25g. Molecular Weight 299.34. See USA prepack pricing. |  |
| 8-anti-Ipratropium Bromide | 8-anti-Ipratropium Bromide. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 8-Azoniabicyclo[3.2.1]octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide (1:1), (3-endo,8-anti)-, 8-Azoniabicyclo[3.2.1]octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide, (3-endo,8-anti)- (9CI). CAS No. 58073-59-9. Molecular formula: C20H30NO3.Br. Mole weight: 412.36. Catalog: APS58073599. Format: Neat. | |
| 8'-Apo-b-carotenal | 8'-Apo-b-carotenal. Group: Biochemicals. Alternative Names: 8'-Apo-b-caroten-8'-al. Grades: Highly Purified. Pack Sizes: 1mg, 2mg, 5mg. US Biological Life Sciences. | Worldwide |
| 8'-apo-β-carotenoid 14',13'-cleaving dioxygenase | A thiol-dependent enzyme isolated from rat and rabbit. Unlike EC 1.13.11.63, β-carotene-15,15'-dioxygenase, it is not active towards β-carotene. The secondary product has not been characterized, but may be (3E,5E)-7-hydroxy-6-methylhepta-3,5-dien-2-one. Group: Enzymes. Synonyms: 8'-apo-β-carotenol:O2 oxidoreductase (14',13'-cleaving). Enzyme Commission Number: EC 1.13.11.67. CAS No. 198028-39-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-0587; 8'-apo-β-carotenoid 14',13'-cleaving dioxygenase; EC 1.13.11.67; 198028-39-6; 8'-apo-β-carotenol:O2 oxidoreductase (14',13'-cleaving). Cat No: EXWM-0587. |  |
| 8'-apo-carotenoid 13,14-cleaving dioxygenase | Isolated from the bacterium Novosphingobium aromaticivorans. It is less active with 4'-apo-β-carotenal and γ-carotene. Group: Enzymes. Synonyms: NACOX1 (gene name). Enzyme Commission Number: EC 1.13.11.82. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-0603; 8'-apo-carotenoid 13,14-cleaving dioxygenase; EC 1.13.11.82; NACOX1 (gene name). Cat No: EXWM-0603. | |
| 8-APT-cGMP | 8-APT-cGMP is an isozyme-selective stimulator of cGMP-dependent protein kinase I a with a prenference for type I a over I by a factor of 200. Synonyms: 8- (2- Aminophenylthio)guanosine- 3', 5'- monophosphate, sodium salt. Grades: ≥ 98% by HPLC. CAS No. 144509-87-5. Molecular formula: C16H16N6O7PS · Na. Mole weight: 490.4. | |
| 8arm-PEG10K 7arm-OH, 1arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| 8arm-PEG10K 7arm-OH, 1arm-COOH | Hexaglycerol core, average Mn 10000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K 7arm-OH, 1arm-COOH, tripentaerythritol core | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K 7arm-OH, 1arm-COOH, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG 7arm-OH, 1arm-COOH, tripentaerythritol core, 8arm PEG, 7arm-Hydroxyl, 1arm-Carboxyl. Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-Acrylate | Hexaglycerol core, average Mn 10000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-Acrylate, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: 3d printing materials poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-ACLT, 8arm-PEG-Acrylate, tripentaerythritol core. Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-Acrylate, tripentaerythritol core | average Mn 10,000. Group: Synthetic polymers for 3d printing. | |
| 8arm-PEG10K-COOH, hexaglycerol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-COOH, hexaglycerol core, 8arm-PEG-COOH. Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-COOH, hexaglycerol core | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-COOH, tripentaerythritol core | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-COOH, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-COOH, tripentaerythritol core, 8arm-PEG-COOH. Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-Maleimide | 8arm-PEG10K-Maleimide. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-Maleimide | tripentaerythritol core, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-Maleimide | hexaglycerol core, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8-arm PEG10K-Methacrylate (hexaglycerol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| 8-arm PEG10K-Methacrylate (tripentaerythritol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-NH2, hexaglycerol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-NH2, hexaglycerol core, 8arm-PEG-NH2. Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-NH2, hexaglycerol core | HCl Salt, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-NH2, tripentaerythritol core | HCl Salt, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-NH2, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-NH2, 8arm-PEG-NH2, tripentaerythritol core. Molecular formula: average Mn 10000. | |
| 8-arm PEG10K-PCL2K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8-arm PEG10K-PLA2K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-SH. Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-SH | hexaglycerol core, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-SH, tripentaerythritol core | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-SH, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-SH, tripentaerythritol core, 8arm-PEG-SH. Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-Succinimidyl Glutarate | 8arm-PEG10K-Succinimidyl Glutarate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-Succinimidyl Succinate | 8arm-PEG10K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-Vinylsulfone, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-VS, 8arm-PEG-Vinylsulfone, tripentaerythritol core. Molecular formula: average Mn 10000. | |
| 8arm-PEG10K-Vinylsulfone, tripentaerythritol core | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG15K-Succinimidyl Glutarate | 8arm-PEG15K-Succinimidyl Glutarate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG15K-Succinimidyl Succinate | 8arm-PEG15K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K 7arm-OH, 1arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000. | |
| 8arm-PEG20K 7arm-OH, 1arm-COOH | Hexaglycerol core, average Mn 20000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K 7arm-OH, 1arm-COOH, tripentaerythritol core | average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K 7arm-OH, 1arm-COOH, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG 7arm-OH, 1arm-COOH, tripentaerythritol core, 8arm PEG, 7arm-Hydroxyl, 1arm-Carboxyl. Molecular formula: average Mn 20000. | |
| 8arm-PEG20K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-Acrylate, hexaglycerol core. Molecular formula: average Mn 20000. | |
| 8arm-PEG20K-Acrylate | tripentaerythritol core, average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-Acrylate, hexaglycerol core | average Mn 20,000. Group: Synthetic polymers for 3d printing. | |
Our database is helping our users find suppliers everyday.
